Recherche en direct
TopFind récupère les correspondances les plus récentes pour votre recherche.
Nous avons examiné 58 résultats en direct pour besremi ropeginterferon alfa 2b et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Pharmaceuticals et Haematology.
Source: PharmaEssentia Singapore Pte. Ltd.
Description
Besremi is a prescription-only biological therapeutic specifically approved for the treatment of Polycythemia Vera (PV) in adults. This long-acting monopegylated interferon is delivered as a 500 micrograms/mL solution for injection in a prefilled syringe, designed for convenient administration and prolonged therapeutic effect in managing myeloproliferative neoplasms (MPN). It was officially launched in Singapore in September 2024 following approval by the Health Sciences Authority (HSA).
Idéal pour
Patients with Polycythemia Vera, Long Acting interferon therapy, Specialized haematology care et Prescription biological treatments
Évaluation
Source: PharmaEssentia
Description
Besremi (ropeginterferon alfa-2b) is a solution for injection provided in a 500 mcg/mL pre-filled syringe. It is a monopegylated interferon specifically indicated for the treatment of adults with Polycythemia Vera (PV). It was recently registered by the Health Sciences Authority (HSA) in May 2024 and launched in Singapore in September 2024 as a new long-acting interferon option.
Idéal pour
Polycythemia Vera patients, Long Acting interferon therapy, Newly registered HSA treatments et Hematology patients
Évaluation
Source: Centre for Clinical Haematology (CFCH)
Description
Professional medical service involving the specialist consultation, prescription, and clinical administration of Besremi (ropeginterferon alfa-2b) for the treatment of Polycythemia Vera. The service includes patient monitoring and expert management of Myeloproliferative Neoplasms (MPNs) in a clinical setting.
Idéal pour
MPN patient management, Supervised biological injections, Specialist haematology advice et Private oncology care
Évaluation
| Comparer | Besremi (ropeginterferon alfa-2b) | Besremi | Besremi Clinical Consultation and Administration |
|---|---|---|---|
| Source | PharmaEssentia Singapore Pte. Ltd. | PharmaEssentia | Centre for Clinical Haematology (CFCH) |
| Description | Besremi is a prescription-only biological therapeutic specifically approved for the treatment of Polycythemia Vera (PV) in adults. This long-acting monopegylated interferon is delivered as a 500 micrograms/mL solution for injection in a prefilled syringe, designed for convenient administration and prolonged therapeutic effect in managing myeloproliferative neoplasms (MPN). It was officially launched in Singapore in September 2024 following approval by the Health Sciences Authority (HSA). | Besremi (ropeginterferon alfa-2b) is a solution for injection provided in a 500 mcg/mL pre-filled syringe. It is a monopegylated interferon specifically indicated for the treatment of adults with Polycythemia Vera (PV). It was recently registered by the Health Sciences Authority (HSA) in May 2024 and launched in Singapore in September 2024 as a new long-acting interferon option. | Professional medical service involving the specialist consultation, prescription, and clinical administration of Besremi (ropeginterferon alfa-2b) for the treatment of Polycythemia Vera. The service includes patient monitoring and expert management of Myeloproliferative Neoplasms (MPNs) in a clinical setting. |
| Idéal pour | Patients with Polycythemia Vera, Long Acting interferon therapy, Specialized haematology care et Prescription biological treatments | Polycythemia Vera patients, Long Acting interferon therapy, Newly registered HSA treatments et Hematology patients | MPN patient management, Supervised biological injections, Specialist haematology advice et Private oncology care |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"Besremi (ropeginterferon alfa-2b) de PharmaEssentia Singapore Pte. Ltd.."
Je l'ai choisi parce que As the official local subsidiary of the manufacturer, this entity provides the primary source-backed pharmaceutical supply and regulatory oversight for Besremi in Singapore.